Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2B, Randomized, Double Blind, Active Comparator, Multicenter, Safety, and Efficacy Trial of ATX-101 in Subjects Undergoing Total Knee Arthroplasty

NCT05260008 is registered in ClinicalTrials.gov with Allay Therapeutics, Inc. as lead sponsor.

NCT NCT05260008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05260008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2B, Randomized, Double Blind, Active Comparator, Multicenter, Safety, and Efficacy Trial of ATX-101 in Subjects Undergoing Total Knee Arthroplasty
Lead sponsor
Allay Therapeutics, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
June 7, 2022
Completion date
January 15, 2024
Enrollment
112 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute postoperative pain